Last quarter (Q4 2022), Biotest's total revenue was $155.30M, an increase of 7.70% from the same quarter last year. In Q4, Biotest's net income was $2.10M. See Biotest’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 516.10M	$ 516.10M	$ 515.60M	$ 484.20M	$ 419.10M	$ 400.30M
Cost of Revenue	$ 391.30M	$ 391.20M	$ 434.90M	$ 354.10M	$ 290.30M	$ 265.50M
Gross Profit	$ 124.80M	$ 124.90M	$ 80.70M	$ 130.10M	$ 128.80M	$ 134.80M
Operating Expense	$ 139.90M	$ 133.40M	$ 132.80M	$ 132.60M	$ 135.50M	$ 132.30M
Operating Income	$ -15.10M	$ -8.50M	$ -52.10M	$ -2.50M	$ -6.70M	$ 2.50M
Net Non Operating Interest Income Expense	$ -22.70M	$ -22.80M	$ -15.70M	$ -15.80M	$ -10.70M	$ -16.50M
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ -30.80M	$ -30.80M	$ -62.60M	$ -30.00M	$ -1.30M	$ -6.00M
Tax Provision	$ 800.00K	$ 800.00K	$ 700.00K	$ 1.40M	$ 3.40M	$ 6.90M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -32.10M	$ -32.10M	$ -63.80M	$ -31.80M	$ -5.10M	$ 181.30M
Basic EPS	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted EPS	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Basic Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 531.20M	$ 524.60M	$ 567.70M	$ 486.70M	$ 425.80M	$ 397.80M
Net Income From Continuing And Discontinued Operation	$ -31.70M	$ -31.70M	$ -63.40M	$ -31.40M	$ -4.70M	$ 181.70M
Normalized Income	$ -31.70M	$ -32.84M	$ -65.08M	$ -29.58M	$ -15.83M	$ -15.00M
Interest Expense	$ 19.60M	$ 19.70M	$ 13.20M	$ 14.20M	$ 10.70M	$ 10.90M
EBIT	$ -11.20M	$ -11.10M	$ -49.40M	$ -15.80M	$ 9.40M	$ 4.90M
EBITDA	$ -11.20M	$ 24.70M	$ -18.30M	$ 13.90M	$ 41.10M	$ 29.60M

Currency in USD

Biotest Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing